ANVS CIK: 1477845

Annovis Bio, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−9.13
FY22:
−17.3
FY23:
−40.0
FY24:
−21.9
FY25:
−25.6
Change from FY21 to FY25
millions USD
FY21:
46.7
FY22:
0.00
FY23:
17.3
FY24:
26.7
FY25:
34.6
millions USD
FY21:
37.6
FY22:
−17.3
FY23:
−22.6
FY24:
4.80
FY25:
8.98

All amounts in millions USD Data source:SEC EDGAR